Vimarsana
Biggest News Aggregation in the World

Page 5 - Priya Singhal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Priya Singhal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Priya Singhal Today - Breaking & Trending Today

Barclays Trims Biogen (NASDAQ:BIIB) Target Price to $200.00 - Vimarsana News

Barclays Trims Biogen (NASDAQ:BIIB) Target Price to $200.00

Biogen (NASDAQ:BIIB – Free Report) had its target price trimmed by Barclays from $215.00 to $200.00 in a report published on Thursday morning, Benzinga reports. They currently have an equal weight rating on the biotechnology company’s stock. BIIB has been the topic of several other research reports. Wedbush upped their target price on Biogen from […]

Gitterman Wealth Management LLC Purchases New Shares in Biogen Inc. (NASDAQ:BIIB) - Vimarsana News

Gitterman Wealth Management LLC Purchases New Shares in Biogen Inc. (NASDAQ:BIIB)

Gitterman Wealth Management LLC purchased a new stake in Biogen Inc. (NASDAQ:BIIB – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 980 shares of the biotechnology company’s stock, valued at approximately $254,000. Other institutional investors have also added to or reduced […]

Intellectus Partners LLC Cuts Stock Position in Biogen Inc. (NASDAQ:BIIB) - Vimarsana News

Intellectus Partners LLC Cuts Stock Position in Biogen Inc. (NASDAQ:BIIB)

Intellectus Partners LLC lessened its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,563 shares of the biotechnology company’s stock after selling 50 shares during the quarter. Intellectus Partners LLC’s holdings in Biogen […]

Biogen's (BIIB) Buy Rating Reiterated at Needham & Company LLC - Vimarsana News

Biogen's (BIIB) Buy Rating Reiterated at Needham & Company LLC

Needham & Company LLC reaffirmed their buy rating on shares of Biogen (NASDAQ:BIIB – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. The brokerage currently has a $294.00 target price on the biotechnology company’s stock. Other equities research analysts have also recently issued reports about the company. Canaccord Genuity […]

Biogen Inc. (NASDAQ:BIIB) to Post Q2 2024 Earnings of $3.43 Per Share, Wedbush Forecasts - Vimarsana News

Biogen Inc. (NASDAQ:BIIB) to Post Q2 2024 Earnings of $3.43 Per Share, Wedbush Forecasts

Biogen Inc. (NASDAQ:BIIB – Free Report) – Research analysts at Wedbush decreased their Q2 2024 earnings per share estimates for shares of Biogen in a report issued on Wednesday, April 24th. Wedbush analyst L. Chico now forecasts that the biotechnology company will post earnings per share of $3.43 for the quarter, down from their previous […]